AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 46 filers reported holding AYTU BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | -63.4% | 81,989 | +39.4% | 0.00% | – |
Q2 2022 | $41,000 | -68.5% | 58,800 | -51.0% | 0.00% | – |
Q1 2022 | $130,000 | -52.9% | 120,080 | -41.6% | 0.00% | – |
Q4 2021 | $276,000 | -57.7% | 205,456 | -9.2% | 0.00% | – |
Q3 2021 | $652,000 | -70.8% | 226,371 | -49.3% | 0.00% | – |
Q2 2021 | $2,236,000 | +254.9% | 446,488 | +438.5% | 0.00% | – |
Q1 2021 | $630,000 | – | 82,920 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OCCUDO QUANTITATIVE STRATEGIES LP | 73,259 | $211,000 | 0.02% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 10,880 | $31,000 | 0.01% |
WINTON GROUP Ltd | 57,452 | $165,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 80,864 | $233,000 | 0.00% |
Renaissance Technologies | 660,604 | $1,903,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 360,256 | $1,038,000 | 0.00% |
D. E. Shaw & Co., Inc. | 193,359 | $557,000 | 0.00% |
COMMONWEALTH EQUITY SERVICES, LLC | 107,718 | $310,000 | 0.00% |
Sigma Planning Corp | 10,020 | $29,000 | 0.00% |
Schonfeld Strategic Advisors LLC | 20,200 | $58,000 | 0.00% |